List view / Grid view
8 August 2018 | By SUEZ
Data integrity and 21 CFR Part 11/EU Annex 11 requirements are hot topics when ageing analytical equipment is to be replaced. Common questions from pharma and biopharmaceutical manufacturers include: is the new technology compliant with auditor expectations? Can we get the right data saved the right way in the right…
7 August 2018 | By Mike Stones
Maintaining public confidence in the use of Big Data for health research is essential, according to international researchers.
7 August 2018 | By European Pharmaceutical Review
Researchers found that more than one quarter (26 per cent) of patients taking Aimovig 70mg were migraine free after month 15...
19 July 2018 | By Dave P Elder, Mike Stones
More guidance is needed on the appropriate control of non-mutagenic impurities during clinical development, explains Dave P Elder, JPAG Member and pharmaceutical industry consultant, in this audio interview.
9 May 2018 | By Reading Scientific Services Limited
Reading Scientific Services Ltd (RSSL) has appointed Katarzyna Szymaniec to lead its accredited pharmaceutical training business and align its strategic development with the diverse needs of professionals working within the sector...
1 March 2018 | By European Pharmaceutical Review
In this edition, two leading analytical equipment suppliers explain how their products meet current industry requirements.
1 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
New permanent building to be completed by 15 November 2019...
8 January 2018 | By Allan Hillgrove - Boehringer Ingelheim
Allan Hillgrove, Member of the Board of Managing Directors with responsibility for the Human Pharma Business Unit at Boehringer Ingelheim, tells EPR about some of his company’s achievements that he is most proud of, and describes how it will face the digital challenge...
8 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Following the Brexit vote, the UK is already seeing problems in filling senior positions at life sciences companies, with their average “slate” of candidates falling from around 40% non-UK nationals to just 15% non-UK candidates on average...
4 January 2018 | By Beatriz Faro - Pfizer
For Pfizer, putting patients first guides its actions, informs its strategic decisions and unifies colleagues in every region and function across the company. Beatriz Faro, Regional President, Internal Medicine, International Developed Markets at Pfizer, explains how the company’s philosophy is taking the business forward...
2 January 2018 | By Christof Hohne
Christof Hohne, partner at patent law firm EIP, discusses second medical use claims and compulsory licences...
21 December 2017 | By European Pharmaceutical Review
European Pharmaceutical Review has brought you the most up-to-date and relevant pharmaceutical science for the past 21 years. This anniversary supplement brings you a selection of topical views from across the industry, reviewing progress over that time, as well as looking to the future.
19 December 2017 | By Katheryn Shea, Maria Thompson
On 30 March 2019 the UK is set to leave the European Union (EU), a process that has become popularly known as Brexit. One little talked-about aspect of this move in the mainstream media is the impact it will have on the British life science community. Researchers and industry leaders…
28 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Following new Fraser of Allander Institute analysis, the new Director of ABPI Scotland has called upon the Scottish Government to continue to support and prioritise strategic investments in Scotland’s research, development and manufacturing capabilities...
20 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Hemlibra has been approved to prevent the frequency of bleeding episodes in patients who have developed FVIII inhibitors...
Send this to a friend
Follow: